Europe - AMS:PHIA - NL0000009538 - Common Stock
The current stock price of PHIA.AS is 24.98 EUR. In the past month the price increased by 2.52%. In the past year, price decreased by -0.53%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 16.66 | 102.17B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.67 | 50.12B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.96 | 23.51B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 16.9 | 23.43B | ||
| BIM.PA | BIOMERIEUX | 28.13 | 12.85B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 24.91 | 3.81B | ||
| DIA.MI | DIASORIN SPA | 17.34 | 3.37B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.73 | 1.30B | ||
| DRW8.DE | DRAEGERWERK AG | 9.3 | 1.13B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 26.34 | 987.10M | ||
| ELN.MI | EL.EN. SPA | 17.45 | 896.17M | ||
| GVS.MI | GVS SPA | 47.22 | 804.01M |
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,263 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
KONINKLIJKE PHILIPS NV
High Tech Campus 5
Eindhoven NOORD-BRABANT NL
Employees: 66678
Phone: 31205977777
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,263 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
The current stock price of PHIA.AS is 24.98 EUR. The price increased by 2.25% in the last trading session.
PHIA.AS does not pay a dividend.
PHIA.AS has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
The PE ratio for KONINKLIJKE PHILIPS NV (PHIA.AS) is 17.35. This is based on the reported non-GAAP earnings per share of 1.44 and the current share price of 24.98 EUR.
KONINKLIJKE PHILIPS NV (PHIA.AS) currently has 66678 employees.
ChartMill assigns a technical rating of 7 / 10 to PHIA.AS. When comparing the yearly performance of all stocks, PHIA.AS turns out to be only a medium performer in the overall market: it outperformed 40.26% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS. PHIA.AS may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months PHIA.AS reported a non-GAAP Earnings per Share(EPS) of 1.44. The EPS increased by 12.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.91% | ||
| ROA | 0.61% | ||
| ROE | 1.56% | ||
| Debt/Equity | 0.69 |
27 analysts have analysed PHIA.AS and the average price target is 27.39 EUR. This implies a price increase of 9.66% is expected in the next year compared to the current price of 24.98.
For the next year, analysts expect an EPS growth of 0.24% and a revenue growth -1.93% for PHIA.AS